title: Is it too soon to start reporting HER2 genetic heterogeneity?
authors.forename: Constance
authors.initials: C
authors.lastname: Albarracin
authors.forename: Mary E
authors.initials: ME
authors.lastname: Edgerton
authors.forename: Michael Z
authors.initials: MZ
authors.lastname: Gilcrease
authors.forename: Lei
authors.initials: L
authors.lastname: Huo
authors.forename: Savitri
authors.initials: S
authors.lastname: Krishnamurthy
authors.forename: Lavinia P
authors.initials: LP
authors.lastname: Middleton
authors.forename: Erika
authors.initials: E
authors.lastname: Resetkova
authors.forename: Aysegul A
authors.initials: AA
authors.lastname: Sahin
authors.forename: Nour
authors.initials: N
authors.lastname: Sneige
authors.forename: W Symmans
authors.initials: WS
authors.lastname: Fraser
authors.forename: Yun
authors.initials: Y
authors.lastname: Wu
mesh_terms: D001943:Breast Neoplasms / Q000235:genetics; D005260:Female; D005784:Gene Amplification; D018740:Genetic Heterogeneity; D006801:Humans; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000235:genetics*
chemical_list: D018719:Erb-b2 Receptor Tyrosine Kinases; C508053:ERBB2 protein, human